🌍 Overview
Tuberculosis (TB) remains the world’s leading infectious disease killer after COVID-19, with more than 10 million cases and 1.3 million deaths annually. Over the past 12 months, progress has been uneven: while global TB incidence continues a slow decline, multidrug-resistant TB (MDR-TB) remains a major challenge, especially in Eastern Europe, Central Asia, and parts of Africa.
🔑 Key Global Numbers (2024–25)
Total TB cases (all forms): ~10.6 million worldwide (latest WHO estimate). Deaths (excluding HIV): ~1.3 million. MDR/RR-TB (rifampicin-resistant): ~410,000 cases globally. Treatment coverage: ~63% for MDR-TB patients; cure rates remain <60% in many high-burden countries.
📊 Regional Highlights
Africa: High TB burden, esp. southern Africa (South Africa, Mozambique, Nigeria). HIV/TB co-infection remains critical; ~20–30% of TB patients are also HIV positive. MDR-TB rising in some urban centers.
South-East Asia: ~45% of global TB cases come from India, Indonesia, Bangladesh, Myanmar. India alone: >2.8 million reported TB cases in past 12 months. MDR-TB incidence still climbing in India & Myanmar.
Europe & Central Asia: Eastern Europe + Central Asia = highest MDR-TB prevalence worldwide. In some countries (Belarus, Russia, Ukraine), >30% of new TB cases are MDR-TB.
Americas: Lower burden overall, but Brazil, Peru, Haiti report high case counts. MDR-TB clusters in Peru remain a regional challenge. Western Pacific: China, Philippines, Viet Nam = top three contributors in this region. Expanded rollout of new short MDR-TB regimens (6-month BPaLM) since 2023.
🧭 Interpretation
TB burden remains massive — 10M+ cases annually, with highest loads in South-East Asia & Africa. MDR-TB is the greatest threat to TB elimination goals: >400,000 cases yearly, and in some regions >1 in 3 new cases are resistant. Treatment scale-up of BPaLM regimens (bedaquiline, pretomanid, linezolid, moxifloxacin) offers hope — but access gaps remain. HIV/TB co-epidemic in Africa and vaccine coverage gaps elsewhere (BCG waning efficacy) fuel persistent transmission.
✅ Sources
WHO Global TB Report (2024, 2025 updates) Stop TB Partnership surveillance briefs UNAIDS TB/HIV coinfection data ChatGPT (OpenAI Assistant) — synthesis and narrative construction from cited sources
🔍 SEO Metadata
Meta Title: Global Tuberculosis & MDR-TB Report 2024–25: Burden and Resistance Trends
Meta Description: TB caused >10 million cases and 1.3 million deaths in the past year. MDR-TB remains a growing threat, especially in Eastern Europe, Central Asia, and South-East Asia.
Slug: /tuberculosis-mdrtb-update-2024-2025
Tuberculosis caused ~10.6 million cases and 1.3 million deaths worldwide in the past year. While global incidence slowly declines, multidrug-resistant TB (MDR-TB) is expanding, with Eastern Europe and Central Asia seeing >30% of new TB cases resistant to first-line therapy.